Literature DB >> 19871403

GELATIN-ITS USEFULNESS AND TOXICITY : BLOOD PROTEIN PRODUCTION IMPAIRED BY CONTINUED GELATIN BY VEIN.

F S Robscheit-Robbins1, L L Miller, G H Whipple.   

Abstract

Gelatin given by vein to doubly depleted dogs (anemic and hypoproteinemic) gives no immediate toxic response, no anaphylactoid reactions, and may contribute something to the building of new hemoglobin and plasma protein. Gelatin given by vein during 1 to 2 weeks (total 3 to 17 gm. per kilo) usually causes serious disturbances-inhibition of blood protein production, signs of intoxication, much weight loss, and even death. Gelatin given by vein for 2 to 3 days (total 1 to 3 gm. per kilo) may not cause any recognizable abnormalities, but dogs vary greatly in their response to gelatin by vein. Some dogs may tolerate a total of 7 gm. per kilo without significant disturbance and other dogs may be seriously intoxicated by 2 to 3 gm. per kilo. No one can predict which animal will be least tolerant. Some experiments with gelatin by vein for 2 to 3 days (total gelatin 1 to 2 gm. per kilo) given with and followed by amino acids or casein digests do show absence of intoxication and ample production of new hemoglobin and plasma protein during the weeks following the injection of gelatin. This may suggest possible usefulness of gelatin with amino acids or casein digests in acute emergencies (shock, hemorrhage). These doubly depleted dogs are very susceptible to various injurious agents as compared to normal dogs. They may serve as sensitive testing machines for evaluating plasma substitutes. Where the gelatin by vein inflicts its damage is not clear and there is little if any significant histological evidence but the disturbance of blood protein production implicates the liver. Gelatin of smaller molecular weight (degraded by autoclaving) is no less toxic than the standard gelatin. Gelatin by mouth may contribute to but cannot alone support the production of new hemoglobin and plasma protein. Gelatin by vein has definite limitations in dogs and, by implication, when used in human cases the amount given should be very carefully watched.

Entities:  

Year:  1944        PMID: 19871403      PMCID: PMC2135456          DOI: 10.1084/jem.80.2.145

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  GELATIN AS A PLASMA SUBSTITUTE WITH PARTICULAR REFERENCE TO EXPERIMENTAL HEMORRHAGE AND BURN SHOCK.

Authors:  W M Parkins; C E Koop; C Riegel; H M Vars; J S Lockwood
Journal:  Ann Surg       Date:  1943-08       Impact factor: 12.969

2.  Experimental Studies in Cardiovascular Pathology: V. Effects of Intravenous Injections of Solutions of Gum Arabic, Egg Albumin and Gelatin upon the Blood and Organs of Dogs and Rabbits.

Authors:  W C Hueper
Journal:  Am J Pathol       Date:  1942-09       Impact factor: 4.307

3.  HEMOGLOBIN AND PLASMA PROTEIN : SIMULTANEOUS PRODUCTION DURING CONTINUED BLEEDING AS INFLUENCED BY AMINO ACIDS, PLASMA, HEMOGLOBIN, AND DIGESTS OF SERUM, HEMOGLOBIN, AND CASEIN.

Authors:  F S Robscheit-Robbins; L L Miller; G H Whipple
Journal:  J Exp Med       Date:  1943-04-01       Impact factor: 14.307

  3 in total
  1 in total

1.  I. Antigenicity of oxypolygelatin and gelatin in man.

Authors:  P H MAURER
Journal:  J Exp Med       Date:  1954-11-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.